Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Athlone Pharmaceuticals Limited, Ballymurray, Co. Roscommon, Ireland
Betahistine Dihydrochloride 8mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Betahistine Dihydrochloride 8mg Tablets are white, circular, flat, bevelled edged tablets marked B8 on one side. |
Each tablet contains 8mg betahistine dihydrochloride.
Excipient(s) with known effect: lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Betahistine |
Betahistine dihydrochloride is a histamine-like drug in which pharmacological activity can be attributed to a specific effects and/or more direct influences on recovery mechanisms the vestibular nuclei. It has weak agonist activity at histamine H1 receptors and moderate antagonist activity at H3 receptors. Betahistine may increase blood flow to the cochlear region as well as to the whole brain. |
| List of Excipients |
|---|
|
Povidone K90 |
Blister strips consisting of 250 µm transparent PVC, a 60 g/m² PVDC layer and 20µm hard temper aluminium foil, contained in a carton.
Pack sizes: 60, 84, 90, 100 and 120 tablets.
Athlone Pharmaceuticals Limited, Ballymurray, Co. Roscommon, Ireland
PL 30464/0019
23/03/2000
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
